1-Butyl-2,3,4,5,6,7-hexahydro-3-methyl-2,4,6-trioxo-1H-pyrrolo[2,3-d]pyrimidine-5-acetic acid, 97%, 250mg

2-(5-Fluoro-1H-indazol-3-yl)acetic acid, 95.0%, 1g

5-(bromomethyl)piperidin-2-one, 95.0%, 1g

6-nitro-1,3-benzoxazol-2-amine, 95.0%, 250mg

3-(Aminocarbonyl)pyrazine-2-carboxylic acid, 97.0%, 25g

3,5-Diamino-2-hydroxybenzoic acid, 95.0%, 250mg

1-(2-Chloro-4-pyridyl)-3-phenylurea>98.0%(T)5g

2-Methylimidazo[1,2-a]pyridine-7-carboxylic acid hydrochloride, 95%, 50mg

(R)-3-(Palmitoyloxy)-2-(stearoyloxy)propyl (2-(trimethylammonio)ethyl) phosphate, 98%, 500mg

Hexane-1,2,6-triol, 95.0%, 1g

3,4-Dihydro-2H-benzo[b][1,4]oxazine-7-carboxylic acid, 95.0%, 100mg

Systèmes de dialyse Spectra/Por® Float-A-Lyzer® G2 Volume de remplissage 10 ml, 100–500 dalton(s), 12 pièce(s)

3,5-Dichloro-N,N-dimethylaniline, 98.0%, 25g